To the Editor Rosner et al showed that cognitive processing therapy is more effective than a wait-list condition with treatment advice in adolescents and young adults with abuse-related posttraumatic stress disorder (PTSD). However, there seems to be an unaddressed confounder present in this study in terms of psychopharmacological treatments. To be included in this study, participants must have been “receiving no or stable psychopharmacological medication (for ≥3 weeks).”1 However, the possible confounder of a psychopharmacological treatment is not listed as a demographic variable in the comparison of the groups at baseline. The significance of psychopharmacologic agents in children with PTSD is an area of ongoing study; thus, identifying and further exploring the role of medication in this study could likely expand the generalizability of the findings and the possibilities for clinical application.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Ferguson KB. Posttraumatic Stress Disorder and Cognitive Processing Therapy in Youth. JAMA Psychiatry. 2019;76(10):1097. doi:10.1001/jamapsychiatry.2019.1968
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: